Neonatal Thrombosis

Indian Journal of Pediatrics

Volumn 70, Issue 11, 2003, Pages 903-907

  Saxena, Renu ^a,b   Kannan, M ^a   Choudhry, V P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Lab investigation; Management; Neonates; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ASPHYXIA; CATHETERIZATION; CAUCASIAN; CONFERENCE PAPER; DEHYDRATION; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FIBRINOLYSIS; HEART DISEASE; HETEROZYGOSITY; HUMAN; HYPERCOAGULABILITY; INDWELLING CATHETER; LABORATORY TEST; MATERNAL DIABETES MELLITUS; MORBIDITY; MORTALITY; NEWBORN DISEASE; PATHOGENESIS; PLASMA VISCOSITY; PROTHROMBIN TIME; RACE DIFFERENCE; RISK FACTOR; SEPTICEMIA; THROMBOCYTE; THROMBOSIS;

EID: 0347513060     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02730597     Document Type: Conference Paper

References (32)

1. Schmidt B, Zipursky A. Thrombotic disease in newborn infants. Clin Perinatol 1984; 11: 461-488.
2. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994a; 83(5):1251-1257.
3. Symnasky MR, Fox HA. Umbilical vessel catheterization: indications, management and evaluation of the technique. J Pediatr 1972; 80: 820-826.
4. Wigger HJ, Bransilver BR, Blanc WA. Thrombosis due to catheterization in infants and children. J Pediatr 1970; 76: 1-11.
5. Al Kalay AL, Mazkereth R, Santulli T, Pomerance JJ. Central venous line thrombosis in premature infants: a case management and literature review. Am J Perinatol 1993; 10: 323-326.
6. Bertina RM, Koeleman BPC et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
7. Poort et al. A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
8. Mingers AM, Philapitsch A, Schwarz HP, Zeitler P, Kreth HW. Polymorphonuclear elastase in patients with homozygous type I plasminogen deficiency and ligneous conjunctivitis Seminars in Thrombosis and Hemostasis 1998; 24: 605-612.
9. Tabbutt S, Griswold WR, Ogino MT et al. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. J Perinatol 1994; 14: 66-70.
10. Heller et al. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. Br J Haematol 2000; 111: 534-539.
11. Junker R et al. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999; 19: 2568-2572.
12. Clagett GP, Ledesma DF. Commentary on Lawson JA et al. In situ vein grafts require more secondary procedures than reversed grafts after infrainguinal bypass surgery. Vascular Surgery Outlook 1999; 12(6): 21-22.
13. Walker I D, Greaves M, Preston F E. Guidelines: Investigation and management of heritable thrombophilia. Br J Haematol 2001; 114: 512-528.
14. Manco-Johnson MJ, Abshire TC, Jacobson LJ, Marlar RA. Severe neonatal protein C deficiency: prevalence and thrombotic risk. J Pediatr 1991; 119: 793-798.
15. Payne RM, Martin TC, Bower RJ, Canter CE. Management and follow-up of arterial thrombosis in the neonatal period. J Pediatr 1989; 114: 853-858.
16. Jaiyesimi F, Effiong CE, Lawson EAL. Congenital gangrene of an extremity in a Nigerian neonate. Clin Pediatr 1976; 15: 283-285.
17. Corrigan JI, Neonatal thrombosis and the thrombolytic system: Pathophysilogy and therapy. Am J Pediatr Hematol Oncol 1988; 10: 83-91.
18. Idowu J, Hertzler JH, Philipart AI. Occlusion of abdominal aorta in the newborn. J Pediatr Surg 1986; 21: 971-972.
19. Nazer H, Rajab AA, Qaryouti S, Zubrow A, Razi N, Askin SR et al. Neonatal limb gangrene and renal vein thrombosis. J Pediatr 1987; 146: 429-431.
20. Stravosky M, Iellin A, Spirer Z. Acute ischemia of the limb in a newborn treated successfully by thrombectomy. Am J Surg 1975; 129: 337-340.
21. Johnson D, Rosen JM, Khoury M, Stevenson D. Infarction of the upper limb associated with oligohydramnios and intrauterine compression. J Hand Surg 1988; 13A: 420-422.
22. Turnpenny PD, Stahl S, Bowers D, Bingham P. Peripheral ischemia and gangrene presenting at birth. Eeur J Pediatr 1992; 151: 550-554.
23. Schmidt B, Andrew M. Report of scientific and standardization subcommmittee on neonatal hemostasis. Diagnosis and treatment of neonatal thrombosis. Thromb Hemost 1992; 67: 381-382.
24. Andrew M, Paes B, Johnston M. Development of the human coagulation system in the neonate and young infants. Am J Pediatr Hematol Oncol 1990; 12: 95-104.
25. Hathaway W, Corrigan J. Report of Scientific and Standardisation Subcommittee on Neonatal Haemostasis. Normal coagulation data for fetuses and newborn infants. Thrombosis and Haemostasis 1991; 65: 323-325.
26. Schmidt B, Andrew M (for the subcommittee). Report of the Scientific and Standardization Subcommittee on Neonatal Hemostasis: Diagnosis and treatment of neonatal thrombosis. Thrombosis and Haemostasis 1992; 67: 381-382.
27. Schmidt B, Buchanan M, Ofosu F, Brooker L, Hirsh J, Andrew M. Antithrombotic properties of heparin in a neonatal piglet model of thrombin induced thrombosis Thrombosis and Haemostasis 1988; 60: 289-292.
28. Andrew M, Marzinotto V, Massicotte P, Blanchette V, Ginsberg J, Brill-Edwards P et al. Heparin therapy in pediatric patients: a prospective cohort study Pediatric Research 1994b; 35 : 78-83.
29. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low molecular weight heparin in pediatric patients with thrombotic disease: a dose finding study Journal of Pediatrics 1996; 128: 313-318.
30. Nohe N, Flemmer A, Rümler R, Praun M, Auberger K. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Eur J Pediatr 1999; 158: S134-S139.
31. Chalmers EA, Gibson BES. Thrombolytic therapy in the management of paediatric thromboembolic disease. Brit J Hemat 1999; 104: 14-21.
32. Muller FM, Ehrenthal W, Hafner G, Schranz D. Purpura fulminans in severe congenital protein C deficiency: monitoring of treatment with protein C concentrate. Eur J Pediatr 1996; 155: 20-25.